Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Annals of Behavioral Medicine
Erschienen in: Annals of Behavioral Medicine 3/2015

01.06.2015 | Original Article

Composite Cardiovascular Risk Scores and Neuropsychological Functioning: A Meta-Analytic Review

verfasst von: Jonathan DeRight, Ph.D., Randall S. Jorgensen, Ph.D., Misaell J. Cabral, B.S.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The ability for patients to understand their risk for disease is important to early intervention and effective treatment. The link between individual cardiovascular risk factors and cognition has been well-established.

Purpose

This study investigated the relationship between cognition and a combination of these factors through a single composite risk score.

Methods

This study quantitatively summarized the strength of the association between composite cardiovascular risk scores and cognitive test performance using meta-analytic methods.

Results

One hundred and nine effect sizes were obtained from 19 studies employing 54,564 participants. Composite risk scores showed a significant association (r = −0.16) with cognitive test performance. Cognitive domain and age did not significantly modify this relationship.

Conclusions

Composite cardiovascular risk scores can be useful indicators of future cognition. The development of a dementia risk score using similar risk factors could aid in the assessment and lifestyle interventions of persons at risk for dementia.
Literatur
1.
2.
Centers for Disease Control. Summary health statistics for U.S. Adults: National Health Interview Survey, 2010. Vital and Health Statistics, Series 10, 2012; (Number 252).
3.
4.
5.
6.
* Laughlin GA, McEvoy LK, von Mühlen D, et al. Sex differences in the association of Framingham Cardiac Risk Score with cognitive decline in community-dwelling elders without clinical heart disease. Psychosom Med. 2011; 73: 683-689. doi:10.​1097/​PSY.​0b013e31822f9089​.
7.
8.
9.
* Kaffashian S, Dugravot A, Nabi H, Batty GD, Brunner E, Kivimäki M, Singh-Manoux A. Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: Evidence from the Whitehall II study. Eur Heart J. 2011; 32: 2326–2332. doi: 10.​1093/​eurheartj/​ehr122.
10.
11.
12.
Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011; 77: 461-468.CrossRefPubMedCentralPubMed
13.
Ciobica A, Padurariu M, Bild W, et al. Cardiovascular risk factors as potential markers for mild cognitive impairment and Alzheimer’s disease. Psychiatr Danub. 2011; 23(4): 340-346.PubMed
14.
Seshadri S, Wolf PA, Beiser A, et al. Stroke risk profile, brain volume, and cognitive function: The Framingham offspring study. Neurology. 2004; 63: 1591-1599.CrossRefPubMed
15.
16.
* Llewellyn DJ, Lang IA, Xie J, Huppert FA, Melzer D, Langa KM. Framingham Stroke Risk Profile and poor cognitive function: A population-based study. BMC Neurol. 2008; 8 (12). doi:10.​1186/​147-2377-8-12
17.
Li J, Wang YJ, Zhang M, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011; 76: 1485-1491.CrossRefPubMed
18.
19.
Kivipelto M, Helkala EL, Hänninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology. 2001; 56: 1683-1689.CrossRefPubMed
20.
Seux ML, Thijs L, Forette F, et al. Correlates of cognitive status of old patients with isolated systolic hypertension: the Syt-Eur vascular Demenia project. J Hypertens. 1998; 16: 963-969.CrossRefPubMed
21.
Farmer ME, White LR, Abbott RD, et al. Blood pressure and cognitive performance. The Framingham study. Am J Epidemiol. 1987; 126(6): 1103-1114.PubMed
22.
Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag. 2008; 4(2): 363-381.PubMedCentralPubMed
23.
* Zade D, Beiser A, McGlinchey R, Au R, Seshadri S, Palumbo C, Wolf PA, DeCarli C, Milberg W. Interactive Effects of Apolipoprotein E Type 4 Genotype and Cerebrovascular Risk on Neuropsychological Performance and Structural Brain Changes. J Stroke Cerebrovasc Dis. 2010; 19 (4):261–268. doi:10.1016/j.jstrokecerebrovasdis.2009.05.001
24.
25.
Knopman D, Boland LL, Mosley T, et al. Atherosclerosis risk in communities (ARIC) study investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001; 56: 42-48.CrossRefPubMed
26.
27.
Maineri NL, Xavier FM, Berleze MC, et al. Risk factors for cerebrovascular disease and cognitive function in the elderly. Arq Bras Cardiol. 2007; 89(3): 142-146.CrossRef
28.
29.
Wadley VG, McClure LA, Howard VJ, et al. Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2007; 38: 1143-1147. doi:10.​1161/​01.​STR.​0000259676.​75552.​38.CrossRefPubMed
30.
Starr JM, Deary IJ, Inch S, et al. Age-associated cognitive decline in healthy old people. Age Ageing. 1997; 26: 295-300.CrossRefPubMed
31.
32.
* Smith PJ, Blumenthal JA, Babyak MA, Benson MH, Doraiswamy M, Waugh R, Hinderliter A, Sherwood A. Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. Psychosom Med. 2007; 69 (6):578–586. doi:10.1097/PSY.0b013e31812f7b8e
33.
Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet. 1997; 349: 151-154.CrossRefPubMed
34.
35.
36.
37.
* Unverzagt FW, McClure LA, Wadley VG, Jenny NS, Go RC, Cushman M, Kissela, BM, Kelley BJ, Kennedy R, Moy CS, Howard V, Howard G. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurol. 2011; 77:1729–1736
38.
39.
40.
Scuteri A, Coluccia R, Castello L, et al. Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure. Eur Heart J. 2009; 30: 1525-1529. doi:10.​1093/​eurheartj/​ehp13.CrossRefPubMed
41.
42.
Tanaka S, Tasuda T, Ishida T, et al. Increased serum cholesterol esterification rates predict coronary heart disease and sudden death in a general population. Arterioscler Thromb Vasc Biol. 2013; 33: 1098-1104.CrossRefPubMed
43.
* Brady CB, Spiro III A, McGlinchey-Berroth R, Milberg W, Gaziano JM. Stroke risk predicts verbal fluency decline in healthy older men: Evidence from the normative aging study. J Gerontol: Psychol Sci. 2001;56B (6):340–346
44.
* Weiner MF, Hynan LS, Rossetti H, Warren MW, Cullum CM. The relationship of montreal cognitive assessment scores to Framingham coronary and stroke risk scores. Open J Psychiatry. 2011; 1:49–55
45.
46.
* Jak AJ, Urban S, McCauley A, Bangen KJ, Delano-Wood L, Corey-Bloom J, Bondi MW. Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. J Int Neuropsychol Soc. 2009; 15 (6):890–897. doi:10.1017/S1355617709090638
47.
* Bangen KJ, Delano-Wood L, Wierenga CE, McCauley A, Jeste DV, Salmon DP, Bondi MW. Associations between stroke risk and cognition in normal aging and Alzheimer’s disease with and without depression. Int J Geriat Psychiatry. 2009; 25:175–182. doi:10.1002/gps.2317
48.
Lafosse JM, Reed BR, Mungas D, et al. Fluency and memory differences between ischemic vascular dementia and Alzheimer’s disease. Neuropsychology. 1997; 11: 514-522.CrossRefPubMed
49.
Starkstein SE, Sabe L, Vazquez S, et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer’s disease. Stroke. 1996; 27: 408-414.CrossRefPubMed
50.
Wright RW, Brand RA, Dunn W, et al. How to write a systematic review. Clin Orthop Relat Res. 2007; 455: 23-29.CrossRefPubMed
51.
52.
Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med. 2000; 19: 3127-3131.CrossRefPubMed
53.
54.
Rosenthal R. Meta-analytic procedures for social research. reth ed. Newbury Park: Sage; 1991.CrossRef
55.
Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks: Sage Publications; 2001.
56.
57.
58.
Schmidt FL, Oh IS, Hayes TL. Fixed- versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in results. Br J Math Stat Psychol. 2009; 62(Pt 1): 97-128.CrossRefPubMed
59.
Rocca WA, Petersen RC, Knopman DS, et al. Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States. Alzheimer’s Dementia. 2011; 7(1): 80-93.CrossRefPubMedCentralPubMed
60.
61.
62.
Woodruff BK, Graff-Radford NR, Ferman TJ, et al. Family history of dementia is a risk factor for Lewy body disease. Neurology. 2006; 66(12): 1949-1950.CrossRefPubMed
63.
Sparks DL, Kryscio RJ, Sabbagh MN, et al. Reduced risk of incident AD with elective statin use in a clinical trial cohort. Curr Alzheimer Res. 2008; 5: 416-421.CrossRefPubMed
64.
Gons RA, van Norden AG, de Laat KF, et al. Cigarette smoking is associated with reduced microstructural integrity of cerebral white matter. Brain. 2011; 134(pt 7): 2216-2224. doi:10.​1093/​brain/​awr145.
65.
66.
67.
* Kaffashian S, Dugravot A, Brunner EJ, Sabia S, Ankri J, Kivimaki M, Singh-Manoux A. Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort. Alzheimer’s Dement. 2013; 9:572–579. doi:10.1016/j.jalz.2012.07.001
68.
* Kaffashian S, Dugravot A, Elbaz A, et al. Predicting cognitive decline: a dementia risk score vs the Framingham vascular risk scores. Neurology. 2013; 80:1300–1306. doi:10.1212/WNL.0b013e31828ab370
69.
* Merrill DA, Siddarth P, Kepe V, Raja PV, Saito N, Ercoli LM, Miller KJ, Lavretsky H, Bookheimer SY, Barrio JR, Small GW. Vascular risk and FDDNP-PET influence cognitive performance. J Alzheimers Dis. 2013; 35 (1):147–157. doi:10.3233/JAD-121903
70.
* Sheline YI, Barch DM, Garcia K, Gersing K, Pieper C, Welsh-Bohmer K, Steffens DC, Doraiswamy PM. Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry. 2006; 60 (1):58–65
71.
* Smith PJ, Blumenthal JA, Babyak MA, Hinderliter A, Sherwood A. Association of vascular health and neurocognitive performance in overweight adults with high blood pressure. J Clin Exp Neuropsychol. 2011; 33 (5):559–566
Metadaten
Titel
Composite Cardiovascular Risk Scores and Neuropsychological Functioning: A Meta-Analytic Review
verfasst von
Jonathan DeRight, Ph.D.
Randall S. Jorgensen, Ph.D.
Misaell J. Cabral, B.S.
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Annals of Behavioral Medicine / Ausgabe 3/2015
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-014-9681-0

Weitere Artikel der Ausgabe 3/2015

Annals of Behavioral Medicine 3/2015 Zur Ausgabe

Original Article

Mindfulness Meditation Alleviates Fibromyalgia Symptoms in Women: Results of a Randomized Clinical Trial

Original Article

A Randomized Controlled Trial to Increase HIV Preventive Information, Motivation, and Behavioral Skills in Ugandan Adolescents

Original Article

Daily Social Enjoyment Interrupts the Cycle of Same-Day and Next-Day Fatigue in Women with Fibromyalgia

Original Article

The ABCs of Trait Anger, Psychological Distress, and Disease Severity in HIV

Invited Commentary

Shedding Light on the Association Between Social Support and Adherence in Hypertension: a Comment on Magrin et al.

Original Article

District-Level Primary Care Supply Buffers the Negative Impact of Functional Limitations on Illness Perceptions in Older Adults with Multiple Illnesses

Neu in den Fachgebieten Neurologie und Psychiatrie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Bildnachweise